Conference
A phase Ib study of selumetinib in patients (pts) with previously untreated metastatic Non-Small Cell Lung Cancer (NSCLC) receiving standard chemotherapy: NCIC Clinical Trials Group IND.215. NCT01783197.
Authors
Nicholas GA; Goffin JR; Laurie SA; Robinson AG; Goss GD; Reaume MN; Mates M; Wheatley-Price P; Ellis PM; Juergens RA
Volume
33
Pagination
pp. 8046-8046
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2015
DOI
10.1200/jco.2015.33.15_suppl.8046
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X